Skip to content
Nicholas Kadysh, CEO at PharmAla Biotech episode artwork

Sep 26, 2025 32 min

Nicholas Kadysh, CEO at PharmAla Biotech

from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Hosted by Jesús E. Moreno

In this episode, we welcome Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and named the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has been instrumental in advancing legal and ethical standards, building strong relationships with government, and shaping a regulatory landscape where healthcare innovation can thrive. His leadership has also been recognized by The Peak, which honored him in 2023 for emerging leadership in healthcare. Tune in for an insightful conversation on the future of psychedelic medicine, biotech innovation, and the policies driving change in healthcare.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Nicholas Kadysh, CEO at PharmAla Biotech

0:00 32:51

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere?

This episode is 32 minutes long.

When was this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode published?

This episode was published on September 26, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.